Autolus Therapeutics Sponsored ADR - 48 Year Dividend History | AUTL

Historical dividend payout and yield for Autolus Therapeutics Sponsored ADR (AUTL) since 1971. The current TTM dividend payout for Autolus Therapeutics Sponsored ADR (AUTL) as of April 17, 2019 is $0.00. The current dividend yield for Autolus Therapeutics Sponsored ADR as of April 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.033B $0.001B
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies. The company's pipeline of product candidate involved in development for the treatment of haematological malignancies and solid tumours. Autolus Therapeutics plc is based in London, United Kingdom.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.392B 12.66
Gilead Sciences (GILD) United States $80.676B 10.27
Bio-Techne Corp (TECH) United States $7.127B 48.02